反応式
[C:1]([NH:4][C@@H:5]1[C@@H:10]([O:11][C:12](=[O:14])[CH3:13])[C@H:9]([O:15][C:16](=[O:18])[CH3:17])[C@@H:8]([CH2:19][O:20][C:21](=[O:23])[CH3:22])[O:7][C@H:6]1[NH2:24])(=[O:3])[CH3:2].[CH3:25][C:26]([CH:28]1[C:34](=[O:35])[CH2:33][C:32]([CH3:37])([CH3:36])[CH2:31][C:29]1=[O:30])=O>CO>[C:1]([NH:4][C@@H:5]1[C@@H:10]([O:11][C:12](=[O:14])[CH3:13])[C@H:9]([O:15][C:16](=[O:18])[CH3:17])[C@@H:8]([CH2:19][O:20][C:21](=[O:23])[CH3:22])[O:7][C@H:6]1[NH:24][C:26](=[C:28]1[C:34](=[O:35])[CH2:33][C:32]([CH3:37])([CH3:36])[CH2:31][C:29]1=[O:30])[CH3:25])(=[O:3])[CH3:2]参加物
4
実験手順
A mixture of 2-Acetamido-2-deoxy-3,4,6-tri-O-acetyl-β-D-glucopyranosyl amine (80 mg, 0.23 mmol) and 2-acetyldimedone (55 mg, 0.30 mmol) in MeOH (5 ml) was refluxed for 5 h. The reaction mixture was evaporated, the residue was purified by chromatography using CHCl3/MeOH 10:0.5 as the mobile phase, to give 2-Acetamido-3,4,6-tri-O-acetyl-1,2-dideoxy-1-[1-(4,4-dimethyl-2,6-dioxocyclohex-1-ylidene)ethylamino]-β-D-glucopyranose (19) (70 mg, 60%).
後処理
- temperaturewas refluxed for 5 h
- customThe reaction mixture was evaporated
- customthe residue was purified by chromatography
出典と根拠
- ORDレコード
- ord-c83313feaa6a46669c5c196c4c767541
- 出典データセット
- uspto-grants-2002_10
- 特許番号
- US06462183B1
関連ノート
読み込み中…